News
Most of the 15 million children with a rare disease have no FDA-approved treatments available to them. And when it comes to ...
Investment from largest shareholder strengthens balance sheet, signals insider conviction, and funds Telomir-1’s upcoming IND submission for a rare disease indication ...
2d
Smithsonian Magazine on MSNIn a Remarkable First, a Baby With a Rare Disease Receives Personalized Gene TherapyFor the first time, doctors have treated an infant with a rare genetic disease with a gene-editing therapy tailored ...
Applied Therapeutics’ rare disease drug has failed another late-stage clinical trial, adding to the woes of a candidate that ...
An infant in Philadelphia has been successfully treated with a customized Crispr gene-editing therapy for a rare and deadly ...
Telomir Pharma (NASDAQ: TELO) secured $3M in equity financing from Bayshore Trust, its largest shareholder, at $3 per share ...
While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...
The goal is to reuse key parts of the treatment and simply swap in a custom set of instructions for each patient's specific ...
President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era ...
Alan Alda shared a rare health update about his battle with Parkinson’s disease 10 years after he was first diagnosed. In an ...
Alan Jackson was diagnosed with Charcot-Marie-Tooth disease, a degenerative nerve condition, in 2021. Here's everything to ...
A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results